Bayer Aktiengesellschaft Stock Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.18B 50.62B | Sales 2025 * | 48.08B 51.58B | Capitalization | 26.42B 28.35B |
---|---|---|---|---|---|
Net income 2024 * | 2.08B 2.23B | Net income 2025 * | 3.17B 3.4B | EV / Sales 2024 * | 1.26 x |
Net Debt 2024 * | 33.11B 35.52B | Net Debt 2025 * | 29.67B 31.83B | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
12.3
x | P/E ratio 2025 * |
8.27
x | Employees | - |
Yield 2024 * |
0.41% | Yield 2025 * |
0.86% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |